Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 3 Study of DS-5565 in Asian Patients with Post-herpetic Neuralgia
KCT0001510Phase 3Completed
- Sponsor
- Daiichi Sankyo Co., Ltd.
- Start
- May 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in postherpetic neuralgia (PHN) comparing DS-5565 (mirogabalin) with Placebo (2 arms). Started May 2015; status: completed.
02
Drugs
mirogabalin
03
Conditions
postherpetic neuralgia (PHN)
Beyond the preview
Go deeper on KCT0001510.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on KCT0001510.